Cargando…
Serum Pentraxin 3 as Promising Biomarker for the Long-Lasting Inflammatory Response of COVID-19
Currently, biological markers for COVID-19 disease severity still constitute the main goal of enhancing an efficient treatment to reduce critical consequences such as an abnormal systemic inflammatory response. In this regard, the latest research has shown that Pentraxin 3 (PTX3), a highly conserved...
Autores principales: | Capra, Anna Paola, Crupi, Lelio, Pantò, Giuseppe, Repici, Alberto, Calapai, Fabrizio, Squeri, Raffaele, Ardizzone, Alessio, Esposito, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531731/ https://www.ncbi.nlm.nih.gov/pubmed/37762499 http://dx.doi.org/10.3390/ijms241814195 |
Ejemplares similares
-
The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence
por: Capra, Anna Paola, et al.
Publicado: (2023) -
Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies
por: Capra, Anna Paola, et al.
Publicado: (2023) -
New Insights into the Mechanism of Ulva pertusa on Colitis in Mice: Modulation of the Pain and Immune System
por: Ardizzone, Alessio, et al.
Publicado: (2023) -
Efficacy of the Radical Scavenger, Tempol, to Reduce Inflammation and Oxidative Stress in a Murine Model of Atopic Dermatitis
por: Ardizzone, Alessio, et al.
Publicado: (2023) -
Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro
por: Cucinotta, Laura, et al.
Publicado: (2023)